Abiopharma

News list

Lorrain Daniel S. 🔴 sold 4.2K shares of Contineum Therapeutics, Inc. (CTNM) at $13.43 Transaction Date: Apr 06, 2026 | Filing ID: 023949

Full text

News bot April 6, 2026, 9:44 p.m.
🔍 Lorrain Daniel S. (Executive)

Company: Contineum Therapeutics, Inc. (CTNM)

Report Date: 2026-04-06
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 1
- Total shares sold: 4,170
- Total shares held: 6,842
Detailed Transactions and Holdings:
- Sold 4,170 shares of Class A Common Stock at $13.4326 per share (Direct)
  Date: 2026-04-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 147,712.00 | transaction_form_type: 4 | Footnotes: F1, F2
- Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-04-06 | Code: H | nature_of_ownership: By Spouse | shares_owned_after: 6,842.00
Footnotes:
- F1: These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.
- F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.08 to $13.60, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.